Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;12(2):566-74.
doi: 10.1039/c5mb00736d.

The proteome of methylmalonic acidemia (MMA): the elucidation of altered pathways in patient livers

Affiliations

The proteome of methylmalonic acidemia (MMA): the elucidation of altered pathways in patient livers

Marianna Caterino et al. Mol Biosyst. 2016 Feb.

Abstract

Methylmalonic acidemia (MMA) is a heterogeneous and severe autosomal recessive inborn error of metabolism most commonly caused by the deficient activity of the vitamin B12 dependent enzyme, methylmalonyl-CoA mutase (MUT). The main treatment for MMA patients is the dietary restriction of propiogenic amino acids and carnitine supplementation. Despite treatment, the prognosis for vitamin B12 non-responsive patients remains poor and is associated with neonatal lethality, persistent morbidity and decreased life expectancy. While multi-organ pathology is a feature of MMA, the liver is severely impacted by mitochondrial dysfunction which likely underlies the metabolic instability experienced by the patients. Liver and/or combined liver/kidney transplantation is therefore sometimes performed in severely affected patients. Using liver specimens from donors and MMA patients undergoing elective liver transplantation collected under a dedicated natural history protocol (clinicaltrials.gov: NCT00078078), we employed proteomics to characterize the liver pathology and impaired hepatic metabolism observed in the patients. Pathway analysis revealed perturbations of enzymes involved in energy metabolism, gluconeogenesis and Krebs cycle anaplerosis. Our findings identify new pathophysiologic and therapeutic targets that could be valuable for designing alternative therapies to alleviate clinical manifestations seen in this disorder.

PubMed Disclaimer

Conflict of interest statement

Marianna Caterino declares that she has no conflict of interest. Randy J. Chandler declares that she has no conflict of interest. Jennifer L. Sloan declares that she has no conflict of interest. Kenneth Dorko declares that she has no conflict of interest. Kristina Cusmano-Ozog declares that she has no conflict of interest. Laura Ingenito declares that she has no conflict of interest. Stephen C. Strom declares that she has no conflict of interest. Esther Imperlini declares that she has no conflict of interest. Emanuela Scolamiero declares that he has no conflict of interest. Charles P. Venditti declares that he has no conflict of interest. Margherita Ruoppolo declares that she has no conflict of interest.

Figures

Figure 1
Figure 1
Preparative 2D gel carried out using 24cm pH 3–10 NL in the first dimension and 10% SDS PAGE in the second dimension. The differentially expressed spots, picked-out and used for subsequent identification by mass spectrometry are labeled with official symbols reported in Tables 3 and 4.
Figure 2
Figure 2
A) Western Blot analysis of protein lysates using livers from controls and MMA patients. Proteins were separated on 10% SDS-PAGE and immunoblotted with specific antibodies B) Densitometric measurements of Western Blot analysis of protein lysates using livers from controls and MMA patients. The results are shown as mean ± SD (three replicates).
Figure 3
Figure 3
Metabolic pathways. Proteins marked with ↓ were found downregulated, proteins marked with ↑ were found up regulated.

References

    1. Fenton WA, Gravel RA, Rosenblatt DS. In: The Metabolic and Molecular Bases of Inherited Disease. 8th. Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, et al., editors. New York: McGraw-Hill; 2001. pp. 2165–2192.
    1. de Baulny HO, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM. J Inherit Metab Dis. 2005;28:415–423. - PubMed
    1. Van der Meer SB, Poggi F, Spada M, Bonnefont JP, Ogier H, Hubert P, Depondt E, Rapoport D, Rabier D, Charpentier C, Parvy P, Kamoun P, Saudubray JM. J. Pediatr. 1994;125:903–908. - PubMed
    1. Hauser NS, Manoli I, Graf JC, Sloan J, Venditti CP. Am J Clin Nutr. 2011;93(1):47–56. - PMC - PubMed
    1. Baumgarter ER, Viardot C. J. Inherit. Metab. Dis. 1995;18:138–142. - PubMed

Publication types

Supplementary concepts

Associated data